These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 23818708)

  • 21. Psoriatic arthritis treatment and the risk of herpes zoster.
    Zisman D; Bitterman H; Shalom G; Feldhamer I; Comanesther D; Batat E; Greenberg-Dotan S; Cohen S; Cohen AD
    Ann Rheum Dis; 2016 Jan; 75(1):131-5. PubMed ID: 25261573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis.
    Atzeni F; Costa L; Caso F; Scarpa R; Sarzi-Puttini P
    J Rheumatol Suppl; 2015 Nov; 93():79-81. PubMed ID: 26523064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire.
    Barra L; Pope JE; Payne M
    J Rheumatol; 2009 Jul; 36(7):1421-8. PubMed ID: 19487267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring dactylitis in clinical trials: which is the best instrument to use?
    Healy PJ; Helliwell PS
    J Rheumatol; 2007 Jun; 34(6):1302-6. PubMed ID: 17309128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
    Szentpetery A; McKenna MJ; Murray BF; Ng CT; Brady JJ; Morrin M; Radovits B; Veale DJ; Fitzgerald O
    J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
    Simone D; Nowik M; Gremese E; Ferraccioli GF
    J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience.
    Coates LC; Cawkwell LS; Ng NW; Bennett AN; Bryer DJ; Fraser AD; Emery P; Marzo-Ortega H
    Ann Rheum Dis; 2008 May; 67(5):717-9. PubMed ID: 18055476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive treatment of dactylitis in psoriatic arthritis.
    Rose S; Toloza S; Bautista-Molano W; Helliwell PS;
    J Rheumatol; 2014 Nov; 41(11):2295-300. PubMed ID: 25362714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and management of psoriatic arthritis.
    Balakrishnan C; Madnani N
    Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S18-24. PubMed ID: 23974691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs.
    Cantini F; Niccoli L; Nannini C; Cassarà E; Pasquetti P; Olivieri I; Salvarani C
    Rheumatology (Oxford); 2008 Jun; 47(6):872-6. PubMed ID: 18400836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis.
    Anandarajah AP; Schwarz EM; Totterman S; Monu J; Feng CY; Shao T; Haas-Smith SA; Ritchlin CT
    Ann Rheum Dis; 2008 Mar; 67(3):296-301. PubMed ID: 17967829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leflunomide in psoriatic arthritis: results from a large European prospective observational study.
    Behrens F; Finkenwirth C; Pavelka K; Štolfa J; Šipek-Dolnicar A; Thaçi D; Burkhardt H
    Arthritis Care Res (Hoboken); 2013 Mar; 65(3):464-70. PubMed ID: 23042698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriatic arthritis: current therapy and future approaches.
    Huynh D; Kavanaugh A
    Rheumatology (Oxford); 2015 Jan; 54(1):20-8. PubMed ID: 25125588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of biological agents in the treatment of psoriatic arthritis, literature review].
    Koó E; Brodszky V; Péntek M; Ujfalussy I; Nagy MB; Gulácsi L
    Orv Hetil; 2006 Oct; 147(41):1963-70. PubMed ID: 17120686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.
    Antoni C; Krueger GG; de Vlam K; Birbara C; Beutler A; Guzzo C; Zhou B; Dooley LT; Kavanaugh A;
    Ann Rheum Dis; 2005 Aug; 64(8):1150-7. PubMed ID: 15677701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis.
    Stober C; Ye W; Guruparan T; Htut E; Clunie G; Jadon D
    Rheumatology (Oxford); 2018 Jan; 57(1):158-163. PubMed ID: 29077973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study.
    Fagerli KM; Lie E; van der Heijde D; Heiberg MS; Lexberg AS; Rødevand E; Kalstad S; Mikkelsen K; Kvien TK
    Ann Rheum Dis; 2014 Jan; 73(1):132-7. PubMed ID: 23291385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.
    Coates LC; Tillett W; Chandler D; Helliwell PS; Korendowych E; Kyle S; McInnes IB; Oliver S; Ormerod A; Smith C; Symmons D; Waldron N; McHugh NJ;
    Rheumatology (Oxford); 2013 Oct; 52(10):1754-7. PubMed ID: 23887065
    [No Abstract]   [Full Text] [Related]  

  • 40. Active peripheral inflammation is associated with pro-atherogenic lipid profile in psoriatic arthritis.
    Shrestha A; Bahce-Altuntas A; Mowrey W; Broder A
    Semin Arthritis Rheum; 2016 Dec; 46(3):286-290. PubMed ID: 27373499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.